Bioinformatics Companies in India

Tata Consultancy Services

The latest player in the Indian bioinformatics market is the country’s largest information technology company, Tata Consultancy Services (TCS).

Tata Consultancy Services (TCS), a leading Indian technology services company, has entered into an agreement with Congenia, a biotechnology start-up promoted by Italy’s Genextra Spa group. The Life Sciences R&D division of TCS will work on “P66”, a target protein identified by Congenia as a key protein involved in several age-related diseases and will develop optimised drug leads based on it. TCS will be using modules of its own product “Bio-Suite” to work on the target protein. The optimized lead molecules produced by TCS will be further developed by Congenia through animal trials and eventually human clinical trials.

Congenia, which is 100% owned by Genextra SpA, is a drug discovery company active in research and development in the fields of biotechnology, biomedicine and functional genomics with particular focus on cancer pathologies related to aging and degenerative cell disorders.

The company is developing therapeutic applications based on the Team scientific discoveries and leading edge position in the validation of new gene targets with the aim of becoming a leader in the development of therapeutics to treat the foremost age-related disorders:

- Atherosclerosis
- Diabetic retinopathy
- Emphysema
- Ischemic heart diseases

The company also looks foreward to demonstrade the possibility to use drugs aimed at similar targets in cancer therapeutics.

Congenia S.p.A.
Via dei Bossi, 2/a
20121 Milano
+39 02 36515110
+39 02 36515115 (fax)
congeniainfo@congenia.it